Trident Pharmaceuticals, a biotech company, develops immunomodulatory drugs for the treatment of autoimmune disorders and allergic diseases.
Industries BiopharmaBiotechnologyPharmaceuticalHeadquarters Regions Greater Boston Area, East Coast, New England Founded Date 2006 Founders Robin Brown Operating Status Closed
Company Type For Profit
Phone Number 857-366-8462
Trident Pharmaceuticals is a biotechnology company that engages in the research and development of immunomodulatory drugs for the treatment of autoimmune disorders and allergic diseases. It develops HF1020, an oral biopharmaceutical product that acts by modulating auto reactive T cells, including inducing antigen-specific regulatory T cells as a
mechanism for selectively down-regulating the inflammatory response associated with the treatment of autoimmune disorders such as rheumatoid arthritis, IBD and psoriasis, and allergic diseases.
Trident Pharmaceuticals was founded in 2006 and is based in Boston, Massachusetts.